Article info
Original research
Low-dose adjuvant vaginal cylinder brachytherapy for early-stage non-endometrioid endometrial cancer: recurrence risk and survival outcomes
- Correspondence to Dr Larissa Lee, Department of Radiation Oncology, Brigham and Women's Hospital/Dana-Farber Cancer Institute, Boston, MA 02113, USA; LLEE13{at}Partners.org
Citation
Low-dose adjuvant vaginal cylinder brachytherapy for early-stage non-endometrioid endometrial cancer: recurrence risk and survival outcomes
Publication history
- Received May 18, 2020
- Revision received June 15, 2020
- Accepted June 18, 2020
- First published July 12, 2020.
Article Versions
- You are currently viewing a Previous version of this article (8 December 2020).
- View the most recent version of this article
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© IGCS and ESGO 2020. No commercial re-use. See rights and permissions. Published by BMJ.